Sputnik V vaccine’s efficacy confirmed at 91.4 pc: RDIF, Gamaleya Center

NEW DELHI: Russia’s Sputnik V vaccine is 91.4 per cent effective in providing protection against COVID-19 and has demonstrated 100 per cent efficacy against severe coronavirus cases, the vaccine’s developers said on Monday.

“The efficacy of the Sputnik V vaccine is 91.4 per cent, based on the final control point analysis of data obtained 21 days after administering the first dose,” Gamaleya Center and the Russian Direct Investment Fund (RDIF) said in a statement.

The vaccine demonstrated 100 per cent efficacy against severe coronavirus cases, it added.

Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for accelerated registration of the Sputnik V vaccine in various countries, the statement said. (AGENCIES)